Erratum for the Report "PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D" by E. Toska, H. U. Osmanbeyoglu, P. Castel, C. Chan, R. C. Hendrickson, M. Elkabets, M. N. Dickler, M. Scaltriti, C. S. Leslie, S. A. Armstrong, J. Baselga.

Publikováno v: Science (New York, N.Y.) [Science] 2019 Jan 25; Vol. 363 (6425).

Erratum for the Report 'PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D' by E. Toska, H. U. Osmanbeyoglu, P. Castel, C. Chan, R. C. Hendrickson, M. Elkabets, M. N. Dickler, M. Scaltriti, C. S. Leslie, S. A. Armstrong, J. Baselga

Autor: Pau Castel

Publikováno v: Science. 363

Activating mutations in PIK3CA, the gene encoding phosphoinositide-(3)-kinase α (PI3Kα), are frequently found in estrogen receptor (ER)–positive breast cancer. PI3Kα inhibitors, now in late-stage clinical development, elicit a robust compensator

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06d3941a45d363b944700d6d309cf5d
https://doi.org/10.1126/science.aaw7574

Review on the preparation of carbon membranes derived from phenolic resins for gas separation: From petrochemical precursors to bioresources

Autor: Torres, D., Pérez-Rodríguez, S., Cesari, L., Castel, C., Favre, E., Fierro, V., Celzard, A.

Publikováno v: In Carbon 15 October 2021 183:12-33

Patient Characteristics From Norway's First Heroin-Assisted Treatment Clinics.

Autor: Melis F; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Clausen T; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Castel C; Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Dadras O; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway., De Pirro S; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway., Myklebust LH; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Oldervoll A; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Wüsthoff LE; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Unit for Clinical Research on Addictions, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway., Eide D; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Substance use & addiction journal [Subst Use Addctn J] 2025 Jan; Vol. 46 (1), pp. 13-24. Date of Electronic Publication: 2024 Sep 23.

Prise en charge sociale et cancer de l’enfant

Autor: Castel, C., Sérandour, H., Bouteiller, C., Bouillon, E., Ciriani, C., Peltier Chevillard, V., Bertozzi, A.I., Gandemer, V.

Publikováno v: In Revue d'Oncologie Hématologie Pédiatrique June 2016 4(2):100-105